Aspirin may lower the risks of digestive tract cancers by 22 to 38 percent, a meta-analysis suggests
For all types, the longer people had taken the pain reliever, the better their odds of not developing colorectal, stomach and similar cancers.
View original article
Contributor: Linda Searing
